Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Replication Medical
AddedFeb 15, 2024
UpdatedJun 18, 2026
Replication Medical

Replication Medical

Closed

Replication Medical Inc., a US-based medical device company, develops hydrogel implants for degenerative conditions.

HQ
Cranbury, NJ, US
Founded
2000
Overview
Compare
Fundraising
Employees
Website

Replication Medical Inc., founded in the United States, focuses on developing innovative treatments for degenerative conditions. The company's core mission is to improve patient outcomes through advanced medical devices, specifically hydrogel implants designed to protect soft tissue, such as blood vessels, exposed during surgical procedures. Their market focus is primarily within the United States, targeting healthcare providers and patients dealing with degenerative diseases.

Notable affiliated individuals and investors have not been disclosed. Key achievements include the development and commercialization of their proprietary hydrogel implants, which have garnered attention for their effectiveness in protecting soft tissues. Replication Medical's impact lies in its contribution to enhancing surgical outcomes and patient care in the field of degenerative conditions.

Replication Medical - Similar Companies

Tissue Regeneration logo

Tissue Regeneration

RevOrtho logo

RevOrtho

revortho.com

Adient Medical logo

Adient Medical

adientmedical.com

Biomimedica logo

Biomimedica

biomimedica.com

EmboMedics logo

EmboMedics

BiomedInnovations logo

BiomedInnovations

Xtant Medical Holdings logo

Xtant Medical Holdings

xtantmedical.com

US Medical Innovations logo

US Medical Innovations

Exogenesis logo

Exogenesis

Sofregen Medical logo

Sofregen Medical

Novum Medical logo

Novum Medical

Spinal Balance logo

Spinal Balance

MiMedx Group logo

MiMedx Group

mimedx.com

Cytophil logo

Cytophil

cytophil.com

Histogen logo

Histogen

histogen.com

Replication Medical - Quick Facts

Who are Replication Medical's competitors?

Companies similar to Replication Medical include Tissue Regeneration, RevOrtho, Adient Medical and Biomimedica.

When was Replication Medical founded?

Replication Medical was founded in 2000.

Where is Replication Medical's headquarters located?

Replication Medical's headquarters is located in Cranbury, NJ, US.

How much has Replication Medical raised to-date?

As of May 1, 2021, Replication Medical has raised a total of $1.7M (USD).

Replication Medical - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 9 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 330000Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies